On Tuesday, Palo Alto Networks Inc (NYSE:PANW)’s shares declined -1.19% to $181.85.
Palo Alto Networks Inc (PANW) shared research that uncovers a series of potentially state-sponsored cyberattacks targeting government and military organizations in countries throughout Southeast Asia.
Discovered by the Palo Alto Networks Unit 42 threat intelligence team and dubbed “Operation Lotus Blossom”, the attacks appear to be an attempt to gain inside information on the operation of nation-states throughout the region. The campaign dates as far back as three years and involves targets in Hong Kong, Taiwan, Vietnam, the Philippines and Indonesia.
Over 50 separate attacks have been identified in Operation Lotus Blossom. They all use a custom-built Trojan, named “Elise” to deliver highly targeted spear phishing emails and gain an initial foothold on targeted systems. Unit 42 believes the Elise malware was developed to specifically meet the unique needs of the operation, but also is being used in other non-related attacks by the adversary.
Palo Alto Networks, Inc. provides enterprise security platform to enterprises, service providers, and government entities worldwide. Its platform comprises Next-Generation Firewall that delivers application, user, and content visibility and control, in addition to protection against network-based cyber threats; and Threat Intelligence Cloud that offers central intelligence capabilities, in addition to automated delivery of preventative measures against cyber attacks.
Ameriprise Financial, Inc (NYSE:AMP)’s shares gained 0.32% to $129.76.
Ameriprise Financial, Inc. (AMP) released the results of the new Retirement 2.0SM study, revealing that the majority of Gen Xers (76%) report proactively planning for their retirement, with eight in 10 (79%) respondents presently saving through a 401(k) plan, and seven in 10 (69%) investing in an IRA or similar account.
The Retirement 2.0 study, which surveyed more than 1,500 Americans between the ages of 35-50 with at least $100,000 in investable assets, took a comprehensive look at how Gen X is approaching retirement. The study also explored how they have invested and saved for this major milestone; and how they expect to spend their retirement years. Encouragingly, the study found that Gen Xers began planning for retirement early and started saving at the average age of 26. They anticipate relying on their 401(k) accounts (42%) or IRAs (29%) as their main sources of income during retirement, while pensions (14%) and Social Security (5%) are predictable to take a back seat as primary sources of retirement funding.
Ameriprise Financial, Inc., through its auxiliaries, provides various financial products and services to individual and institutional clients in the United States and internationally. The companys Advice & Wealth Administration segment provides financial planning and advice, in addition to full-service brokerage services primarily to retail clients through its advisors. Its Asset Administration segment offers investment advice and investment products to retail, high net worth, and institutional clients through unassociated third party financial institutions and institutional sales force. This segment’s products comprise U.S. mutual funds and their non-U.S. equivalents, exchange-traded funds, variable product funds underlying insurance, and annuity separate accounts; and institutional asset administration products, such as traditional asset classes, separately managed accounts, individually managed accounts, collateralized loan obligations, hedge funds, collective funds, and property funds.
At the end of Tuesday’s trade, Xenia Hotels & Resorts Inc (NYSE:XHR)‘s shares dipped -0.46% to $23.77.
Xenia Hotels & Resorts Inc (XHR) declared that its Board of Directors has authorized a cash dividend of $0.23 per share of the Company’s common stock for the second quarter of 2015. The dividend will be paid on July 15, 2015 to all holders of record of the Company’s common stock as of the close of business on June 30, 2015.
The Board of Directors also authorized a cash dividend for a partial six month period of $61.11 per share of the Company’s 12.5% Series A Cumulative Non-Voting Preferred Stock for the first six months of 2015. The dividend will be paid on June 30, 2015 to all holders of record of the preferred stock as of the close of business on June 15, 2015.
Xenia Hotels & Resorts, Inc. operates as a self-advised and self-administered REIT that invests in full service hotels in the United States. As of December 31, 2014, it owned 46 hotels comprising 12,636 rooms across 19 states and the District of Columbia. The company is based in Orlando, Florida.
Heron Therapeutics Inc (NASDAQ:HRTX), ended its Tuesday’s trading session with -6.26% loss, and closed at $31.73.
Heron Therapeutics Inc (HRTX) a biotechnology company, recently declared the pricing of an underwritten offering of 4,800,000 shares of its common stock, offered at a price of $24.75 per share. Heron Therapeutics, Inc. has granted the underwriters a 30-day option to purchase up to an additional 720,000 shares of common stock. The offering is predictable to close on or about June 15, 2015, subject to customary closing conditions. Jefferies LLC, Leerink Partners LLC and Cowen and Company, LLC are acting as joint book-runners for the offering. JMP Securities LLC, Brean Capital, LLC and Noble Life Science Partners are acting as co-managers for the offering.
The gross offering size will be about $119 million before deducting customary underwriting discounts and commissions and offering expenses. Heron Therapeutics, Inc. intends to use the net proceeds from the underwritten offering primarily for general corporate purposes, which comprise, but are not limited to, the commercial launch of SUSTOL® (granisetron injection, extended release), if approved, funding the company’s ongoing and future clinical trials, preclinical development work, and for general and administrative expenses, or other product development activities.
Heron Therapeutics, Inc. is a biotechnology company. The Company uses its technology to develop products to address unmet medical needs. Its Biochronomer polymer-based drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals. The Company’s product candidate, SUSTOL (granisetron injection, extended release), is being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV). Sustol is in Phase III Clinical trials. The Company’s product development program also focuses on identifying new delivery methods and formulations utilizing known compounds that may expand or extend the therapeutic effort, or eliminate the drawbacks of current therapies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
